Population Pharmacokinetic Analysis of Tacrolimus in Time‐Dependent Increase of Clearance for Patients with Living‐Donor Liver Transplantation: A Prospective Observational Study
Tacrolimus is a first‐line immunosuppressant used to prevent rejection in living donor liver transplantation (LDLT) and is subject to therapeutic drug monitoring due to its concentration‐dependent effects and side effects. Metabolism of tacrolimus is reduced by the CYP3A5*3 allele. In addition, liver regeneration over...